Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, Mantle-Cell 3Lymphoma, Non-Hodgkin 2Recurrence 1

Interventions

Rituximab 28Cyclophosphamide 14ibrutinib 10Vincristine 10Prednisone 10Doxorubicin 10Bendamustine Hydrochloride 9Radiotherapy 7Peripheral Blood Stem Cell Transplantation 6Filgrastim 6zanubrutinib 5acalabrutinib 4Lenalidomide 4Cyclosporine 4orelabrutinib 3Whole-Body Irradiation 3R-CHOP protocol 3Mycophenolic Acid 3Melphalan 3Interferon-alpha 3Etoposide 3Dexamethasone 3Cytarabine 3Cyclosporins 3venetoclax 2liposomal amphotericin B 2fludarabine phosphate 2fludarabine 2VAP-cyclo protocol 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Mantle-Cell × R-CHOP protocol × Clear all
NCT01865110 2025-03-05

R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

The Lymphoma Academic Research Organisation

Phase 3 Completed
623 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT00209209 2017-03-07

MCLelderly

European Mantle Cell Lymphoma Network

Phase 3 Unknown
570 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT00209222 2012-09-10

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

European Mantle Cell Lymphoma Network

Phase 3 Unknown
360 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡